The optimal timing of FDG-PET/CT in non-small cell lung cancer diagnosis and staging in an Australian centre
Abstract Background Clinical practice guidelines and re-imbursement schedules vary in the recommended timing of FDG-PET/CT in the diagnostic evaluation of suspected or confirmed lung cancer. The aim was to estimate the probability of requiring more than one invasive test to complete diagnosis and st...
Main Authors: | Anne Johnson, Richard Norman, Francesco Piccolo, David Manners |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | BMC Pulmonary Medicine |
Online Access: | https://doi.org/10.1186/s12890-021-01564-w |
Similar Items
-
18F-FDG PET/ CT in Staging of Lung Cancer
by: Peng XIE, et al.
Published: (2009-02-01) -
The added value of18F-FDG PET/CT in staging non-small cell lung cancer
by: Aliaa S. Sheha, et al.
Published: (2019-12-01) -
FDG-PET/CT Limited to the Thorax and Upper Abdomen for Staging and Management of Lung Cancer.
by: Anne I J Arens, et al.
Published: (2016-01-01) -
The utility of 18F-FDG PET and PET/CT in the diagnosis and staging of chondrosarcoma: a meta-analysis
by: Qingyu Zhang, et al.
Published: (2020-06-01) -
The Role of F-18- FDG PET and PET/CT in Lung Cancer
by: Evren Tumkaya, et al.
Published: (2013-08-01)